safety concerns with inhaled long-acting beta-agonists (Serevent, etc) for asthma
Please see the FDA's new recommendations for the use of long-acting beta agonists
You'll hear more about safety concerns with inhaled long-acting beta-agonists (Serevent, etc) for asthma.
There are already warnings about a possible increased risk of severe asthma attacks and death.
This is seen when inhaled long-acting beta-agonists are used ALONE for asthma...instead of with an inhaled corticosteroid.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive